Role of matrix Gla protein in parathyroid hormone inhibition of osteoblast mineralization

Cells Tissues Organs

Volumn 181, Issue 3-4, 2006, Pages 166-175

  Gopalakrishnan, Rajaram ^a   Suttamanatwong, Supaporn ^a   Carlson, Ann E ^a   Franceschi, Renny T ^b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MICHIGAN SCHOOL OF DENTISTRY   (United States)

Author keywords

Matrix Gla protein; Mineralization; Osteoblast; Osteopontin; Parathyroid hormone; Vascular calcification

Indexed keywords

4 CARBOXYGLUTAMIC ACID; BISPHOSPHONIC ACID DERIVATIVE; BONE MORPHOGENETIC PROTEIN; COLLAGEN FIBRIL; ETIDRONIC ACID; FETUIN; MATRIX PROTEIN; OSTEOCALCIN; OSTEOPONTIN; PARATHYROID HORMONE; PARATHYROID HORMONE[1-34]; PARATHYROID HORMONE[1-38]; SIALOPROTEIN; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; BIOMINERALIZATION; BLOOD VESSEL CALCIFICATION; BONE DENSITY; BONE MINERAL; BONE MINERALIZATION; CELL DIFFERENTIATION; CONFERENCE PAPER; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; ENZYME INDUCTION; GROWTH PLATE; HUMAN; MOLECULAR MECHANICS; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; OSTEOPOROSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SINGLE DRUG DOSE;

ANIMALS; CALCIFICATION, PHYSIOLOGIC; CALCINOSIS; CALCIUM-BINDING PROTEINS; EXTRACELLULAR MATRIX PROTEINS; MICE; OSTEOBLASTS; OSTEOPONTIN; PARATHYROID HORMONE; SIALOGLYCOPROTEINS; VASCULAR DISEASES;

EID: 33645968982     PISSN: 14226405     EISSN: None     Source Type: Journal    
DOI: 10.1159/000091378     Document Type: Conference Paper

References (75)

1. Armamento-Villareal, R., K. Ziambaras, S.H. Abbasi-Jarhomi, A. Dimarogonas, L. Halstead, A. Fausto, L.V. Avioli, R. Civitelli (1997) An intact N terminus is required for the anabolic action of parathyroid hormone on adult female rats. J Bone Miner Res 12: 384-392.
2. Bellows, C.G., H. Ishida, J.E. Aubin, J.N. Heersche (1990) Parathyroid hormone reversibly suppresses the differentiation of osteoprogenitor cells into functional osteoblasts. Endocrinology 127: 3111-3116.
3. Black, D.M., S.L. Greenspan, K.E. Ensrud, L. Palermo, J.A. McGowan, T.F. Lang, P. Garnero, M.L. Bouxsein, J.P. Bilezikian, C.J. Rosen (2003) The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis. N Engl J Med 349: 1207-1215.
4. Boskey, A.L., L. Spevak, E. Paschalis, S.B. Doty, M.D. McKee (2002) Osteopontin deficiency increases mineral content and mineral crystalunity in mouse bone. Calcif Tissue Int 71: 145-154.
5. Bostrom, K., D. Tsao, S. Shen, Y. Wang, L.L. Demer (2001) Matrix GLA protein modulates differentiation induced by bone morphogenetic protein-2 in C3H10T1/2 cells. J Biol Chem 276: 14044-14052.
6. Bringhurst, F.R., G.J. Strewler (2002) Renal and skeletal actions of parathyroid hormone (PTH) and PTH-related protein; in Bilezikian, J.P., L.G. Raisz, G.A. Rodan (eds): Principles of Bone Biology. San Diego, Academic Press, pp 483-514.
7. Brixen, K.T., P.M. Christensen, C. Ejersted, B.L. Langdahl (2004) Teriparatide (biosynthetic human parathyroid hormone 1-34): a new paradigm in the treatment of osteoporosis. Basic Clin Pharmacol Toxicol 94: 260-270.
8. Burr, D.B., T. Hirano, C.H. Turner, C. Hotchkiss, R. Brommage, J.M. Hock (2001) Intermittently administered human parathyroid hormone (1-34) treatment increases intracortical bone turnover and porosity without reducing bone strength in the humerus of ovariectomized cynomolgus monkeys. J Bone Miner Res 16: 157-165.
9. Canalis, E., M. Centrella, W. Burch, T.L. McCarthy (1989) Insulin-like growth factor I mediates selective anabolic effects of parathyroid hormone in bone cultures. J Clin Invest 83: 60-65.
10. Cancela, M.L., B. Hu, P.A. Price (1997) Effect of cell density and growth factors on matrix Gla protein expression by normal rat kidney cells. J Cell Physiol 171: 125-134.
11. Cancela, M.L., P.A. Price (1992) Retinoic acid induces matrix Gla protein gene expression in human cells. Endocrinology 130: 102-108.
12. Demiralp, B., H.L. Chen, A.J. Koh, E.T. Keller, L.K. McCauley (2002) Anabolic effects of parathyroid hormone during bone growth are dependent on c-fos. Endocrinology 143: 4038-4047.
13. Eferl, R., A. Hoebertz, A.F. Schilling, M. Rath, F. Karreth, L. Kenner, M. Amling, E.F. Wagner (2004) The Fos-related antigen Fra-1 is an activator of bone matrix formation. EMBO J 23: 2789-2799.
14. Fujita, T., R. Fukuyama, N. Izumo, T. Hirai, T. Meguro, H. Nakamuta, M. Koida (2001) Transactivation of core binding factor alphal as a basic mechanism to trigger parathyroid hormone-induced osteogenesis. Jpn J Pharmacol 86: 405-416.
15. Galvin, K.M., M.J. Donovan, C.A. Lynch, R.I. Meyer, R.J. Paul, J.N. Lorenz, V. Fairchild-Huntress, K.L. Dixon, J.H. Dunmore, M.A. Gimbrone, Jr., D. Falb, D. Huszar (2000) A role for smad6 in development and homeostasis of the cardiovascular system. Nat Genet 24: 171-174.
16. Giachelli, C.M., N. Bae, M. Almeida, D.T. Denhardt, C.E. Alpers, S.M. Schwartz (1993) Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaques. J Clin Invest 92: 1686-1696.
17. Gopalakrishnan, R., H. Ouyang, M.J. Somerman, L.K. McCauley, R.T. Franceschi (2001) Matrix gamma-carboxyglutamic acid protein is a key regulator of PTH-mediated inhibition of mineralization in MC3T3-E1 osteoblast-like cells. Endocrinology 142: 4379-4388.
18. Hauschka, P.V., J.B. Lian, D.E. Cole, C.M. Gundberg (1989) Osteocalcin and matrix Gla protein: vitamin K-dependent proteins in bone. Physiol Rev 69: 990-1047.
19. Herrmann, S.M., C. Whatling, E. Brand, V. Nicaud, J. Gariepy, A. Simon, A. Evans, J.B. Ruidavets, D. Arveiler, G. Luc, L. Tiret, A. Henney, F. Cambien (2000) Polymorphisms of the human matrix gla protein (MGP) gene, vascular calcification, and myocardial infarction. Arterioscler Thromb Vasc Biol 20: 2386-2393.
20. Hock, J.M., L.A. Fitzpatrick, J.P. Bilezikian (2002) Actions of parathyroid hormone; in Bilezikian, J.P., L.G. Raisz, G.A. Rodan (eds): Principles of Bone Biology. San Diego, Academic Press, pp 463-481.
21. Hock, J.M., I. Gera (1992) Effects of continuous and intermittent administration and inhibition of resorption on the anabolic response of bone to parathyroid hormone. J Bone Miner Res 7: 65-72.
22. Hruska, K.A., S. Mathew, G. Saab (2005) Bone morphogenetic proteins in vascular calcification. Circ Res 97: 105-114.
23. Jilka, R.L., R.S. Weinstein, T. Bellido, P. Roberson, A.M. Parfitt, S.C. Manolagas (1999) Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone. J Clin Invest 104: 439-446.
24. Kirfel, J., M. Kelter, L.M. Cancela, P.A. Price, R. Schule (1997) Identification of a novel negative retinoic acid responsive element in the promoter of the human matrix Gla protein gene. Proc Natl Acad Sci USA 94: 2227-2232.
25. Kitahara, K., M. Ishijima, S.R. Rittling, K. Tsuji, H. Kurosawa, A. Nifuji, D.T. Denhardt, M. Noda (2003) Osteopontin deficiency induces parathyroid hormone enhancement of cortical bone formation. Endocrinology 144: 2132-2140.
26. Koh, A.J., C.A. Beecher, T.J. Rosol, L.K. McCauley (1999) 3′, 5′-Cyclic adenosine monophosphate avtivation in osteoblastic cells: effects on parathyroid hormone-1 receptors and osteoblastic differentiation in vitro. Endocrinology 140: 3154-3162.
27. Krishnan, V., T.L. Moore, Y.L. Ma, L.M. Helvering, C.A. Frolik, K.M. Valasek, P. Ducy, A.G. Geiser (2003) Parathyroid hormone bone anabolic action requires cbfa1/runx2-dependent signaling. Mol Endocrinol 17: 423-435.
28. Kurland, E.S., F. Cosman, D.J. McMahon, C.J. Rosen, R. Lindsay, J.P. Bilezikian (2000) Parathyroid hormone as a therapy for idiopathic osteoporosis in men: effects on bone mineral density and bone markers. J Clin Endocrinol Metab 85: 3069-3076.
29. Lacey, D.L., E. Timms, H.L. Tan, M.J. Kelley, C.R. Dunstan, T. Burgess, R. Elliott, A. Colombero, G. Elliott, S. Scully, H. Hsu, J. Sullivan, N. Hawkins, E. Davy, C. Capparelli, A. Eh, Y.X. Qian, S. Kaufman, I. Sarosi, V. Shalhoub, G. Senaldi, J. Guo, J. Delaney, W.J. Boyle (1998) Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93: 165-176.
30. Lee, S.K., J.A. Loenzo (1999) Parathyroid hormone stimulates TRANCE and inhibits osteoprotegrin ribonucleic acid expression in murine bone marrow cultures: correlation with osteoclast-like cell formation. Endocrinology 140: 3552-3561.
31. Luo, G., P. Ducy, M.D. McKee, G.J. Pinero, E. Loyer, R.R. Behringer, G. Karsenty (1997) Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature 386: 78-81.
32. Ma, Y.L., R.L. Cain, D.L. Halladay, X. Yang, Q. Zeng, R.R. Miles, S. Chandrasekhar, T.J. Martin, J.E. Onyia (2001) Catabolic effects of continuous human PTH(1-38) in vivo is associated with sustained stimulation of RANKL and inhibition of osteoprotegerin and gene-associated bone formation. Endocrinology 142: 4047-4054.
33. McCarthy, T.L., M. Centrella, E. Canalis (1989) Parathyroid hormone enhances the transcript and polypeptide levels of insulin-like growth factor I in osteoblast-enriched cultures from fetal rat bone. Endocrinology 124: 1247-1253.
34. Misof, B.M., P. Roschger, F. Cosman, E.S. Kurland, W. Tesch, P. Messmer, D.W. Dempster, J. Nieves, E. Shane, P. Fratzl, K. Klaushofer, J. Bilezikian, R. Lindsay (2003) Effects of intermittent parathyroid hormone administration on bone mineralization density in iliac crest biopsies from patients with osteoporosis: a paired study before and after treatment. J Clin Endocrinol Metab 88: 1150-1156.
35. Murrils, R.J., L.S. Stein, C.P. Fey, D.W. Dempster (1990) The effects of parathyroid hormone (PTH) and PTH-related peptide on osteoclast resorption of bone slices in vitro: an analysis of pit size and the resorption focus. Endocrinology 127: 2648-2653.
36. Murshed, M., T. Schinke, M.D. McKee, G. Karsenty (2004) Extracellular matrix mineralization is regulated locally; different roles of two gla-containing proteins. J Cell Biol 165: 625-630.
37. Neer, R.M., C.D. Arnaud, J.R. Zanchetta, R. Prince, G.A. Gaich, J.Y. Reginster, A.B. Hodsman, E.F. Eriksen, S. Ish-Shalom, H.K. Genant, O. Wang, B.H. Mitlak (2001) Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 344: 1434-1441.
38. Newman, B., L.I. Gigout, L. Sudre, M.E. Grant, G.A. Wallis (2001) Coordinated expression of matrix gla protein is required during endochondral ossification for chondrocyte survival. J Cell Biol 154: 659-666.
39. O'Brien, K.D., J. Kuusisto, D.D. Reichenbach, M. Ferguson, C. Giachelli, C.E. Alpers, C.M. Otto (1995) Osteopontin is expressed in human aortic valvular lesions. Circulation 92: 2163-2168.
40. Paschalis, E.P., E.V. Glass, D.W. Donley, E.F. Eriksen (2005) Bone mineral and collagen quality in iliac crest biopsies of patients given teriparatide: new results from the fracture prevention trial. J Clin Endocrinol Metab 90: 4644-4649.
41. Pettway, G.J., A. Schneider, A.J. Koh, E. Widjaja, M.D. Morris, J.A. Meganck, S.A. Goldstein, L.K. McCauley (2005) Anabolic actions of PTH(1-34): use of a novel tissue engineering model to investigate temporal effects on bone. Bone 36: 959-970.
42. Price, P.A. (1989) Gla-containing proteins of bone. Connect Tissue Res 21: 51-57; discussion 57-60.
43. Price, P.A., S.A. Faus, M.K. Williamson (1998) Warfarin causes rapid calcification of the elastic lamellae in rat arteries and heart valves. Arterioscler Thromb Vasc Biol 18: 1400-1407.
44. Price, P.A., S.A. Faus, M.K. Williamson (2000) Warfarin-induced artery calcification is accelerated by growth and vitamin D. Arterioscler Thromb Vasc Biol 20: 317-327.
45. Price, P.A., J.E. Lim (2003) The inhibition of calcium phosphate precipitation by fetuin is accompanied by the formation of a fetuin-mineral complex. J Biol Chem 278: 22144-22152.
46. Price, P.A., T.M. Nguyen, M.K. Williamson (2003) Biochemical characterization of the serum fetuin-mineral complex. J Biol Chem 278: 22153-22160.
47. Price, P.A., G.R. Thomas, A.W. Pardini, W.F. Figueira, J.M. Caputo, M.K. Williamson (2002) Discovery of a high molecular weight complex of calcium, phosphate, fetuin, and matrix gamma-carboxyglutamic acid protein in the serum of etidronate-treated rats. J Biol Chem 277: 3926-3934.
48. Price, P.A., M.R. Urist, Y. Otawara (1983) Matrix Gla protein, a new gamma-carboxyglutamic acid-containing protein which is associated with the organic matrix of bone. Biochem Biophys Res Commun 117: 765-771.
49. Qin, L., L.J. Raggatt, N.C. Partridge (2004) Parathyroid hormone: a double-edged sword for bone metabolism. Trends Endocrinol Metab 15: 60-65.
50. Reynolds, J.L., A.J. Joannides, J.N. Skepper, R. McNair, L.J. Schurgers, D. Proudfoot, W. Jahnen-Dechent, P.L. Weissberg, C.M. Shanahan (2004) Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: a potential mechanism for accelerated vascular calcification in ESRD. J Am Soc Nephrol 15: 2857-2867.
51. Rixon, R.H., J.F. Whitfield, L. Gagnon, R.J. Issacs, S. Maclean, B. Chakravarthy, J.P. Durkin, W. Neugebauer, V. Ross, W. Sung, G.E. Willick (1994) Parathyroid hormone fragments may stimulate bone growth in ovariectomized rats by activating adenylyl cyclase. J Bone Miner Res 9: 1179-1189.
52. Roy, M.E., S.K. Nishimoto (2002) Matrix Gla protein binding to hydroxyapatite is dependent on the ionic environment: calcium enhances binding affinity but phosphate and magnesium decrease affinity. Bone 31: 296-302.
53. Sato, Y., R. Nakamura, M. Satoh, K. Fujishita, S. Mori, S. Ishida, T. Yamaguchi, K. Inoue, T. Nagao, Y. Ohno (2005) Thyroid hormone targets matrix Gla protein gene associated with vascular smooth muscle calcification. Circ Res 97: 550-557.
54. Schafer, C., A. Heiss, A. Schwarz, R. Westenfeld, M. Ketteler, J. Floege, W. Muller-Esterl, T. Schinke, W. Jahnen-Dechent (2003) The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification. J Clin Invest 11: 357-366.
55. Schiller, P.C., G. D'Ippolito, B.A. Roos, G.A. Howard (1999) Anabolic or catabolic responses of MC3T3-E1 osteoblastic cells to parathyroid hormone depend on time and duration of treatment. J Bone Miner Res 14: 1504-1512.
56. Schinke, T., M.D. McKee, M. Amling, G. Karsenty (2000) Severe bone mineralization defects in transgenic mice expressing matrix Gla protein in osteoblasts. J Bone Miner Res 15: S170.
57. Schinke, T., M.D. McKee, G. Karsenty (1999) Extracellular matrix calcification: where is the action? Nat Genet 21: 150-151.
58. Schurgers, L.J., K.J. Teunissen, M.H. Knapen, M. Kwaijtaal, R. van Diest, A. Appels, C.P. Reutelingsperger, J.P. Cleutjens, C. Vermeer (2005) Novel conformation-specific antibodies against matrix gamma-carboxyglutamic acid (Gla) protein: undercarboxylated matrix Gla protein as marker for vascular calcification. Arterioscler Thromb Vasc Biol 25: 1629-1633.
59. Shanahan, C.M., N.R. Cary, J.R. Salisbury, D. Proudfoot, P.L. Weissberg, M.E. Edmonds (1999) Medial localization of mineralization-regulating proteins in association with Monckeberg's sclerosis: evidence for smooth muscle cell-mediated vascular calcification. Circulation 100: 2168-2176.
60. Shao, J.S., S.L. Cheng, N. Charlton-Kachigian, A.P. Loewy, D.A. Towler (2003) Teriparatide (human parathyroid hormone (1-34)) inhibits osteogenic vascular calcification in diabetic low density lipoprotein receptor-deficient mice. J Biol Chem 278: 50195-50202.
61. Shapses, S.A., M. Cifuentes, L. Spevak, H. Chowdhury, J. Brittingham, A.L. Boskey, D.T. Denhardt (2003) Osteopontin facilitates bone resorption, decreasing bone mineral crystallinity and content during calcium deficiency. Calcif Tissue Int 73: 86-92.
62. Speer, M.Y., M.D. McKee, R.E. Guldberg, L. Liaw, H.Y. Yang, E. Tung, G. Karsenty, C.M. Giachelli (2002) Inactivation of the osteopontin gene enhances vascular calcification of matrix Gla protein-deficient mice: evidence for osteopontin as an inducible inhibitor of vascular calcification in vivo. J Exp Med 196: 1047-1055.
63. Stheneur, C., M.F. Dumontier, C. Guedes, M.C. Fulchignoni-Lataud, K. Tahiri, G. Karsenty, M.T. Corvol (2003) Basic fibroblast growth factor as a selective inducer of matrix Gla protein gene expression in proliferative chondrocytes. Biochem J 369: 63-70.
64. Suttie, J.W. (1985) Vitamin K-dependent carboxylase. Annu Rev Biochem 54: 459-477.
65. Tam, C.S., J.N. Heersche, T.M. Murray, J.A. Parsons (1982) Parathyroid hormone stimulates the bone apposition rate independently of its resorptive action: differential effects of intermittent and continuous administration. Endocrinology 110: 506-512.
66. Tyson, K.L., J.L. Reynolds, R. McNair, Q. Zhang, P.L. Weissberg, C.M. Shanahan (2003) Osteo/chondrocytic transcription factors and their target genes exhibit distinct patterns of expression in human arterial calcification. Arterioscler Thromb Vasc Biol 23: 489-494.
67. Vattikuti, R., D.A. Towler (2004) Osteogenic regulation of vascular calcification: an early perspective. Am J Physiol Endocrinol Metab 286: E686-E696.
68. Wada, T., M.D. McKee, S. Steitz, C.M. Giachelli (1999) Calcification of vascular smooth muscle cell cultures: inhibition by osteopontin. Circ Res 84: 166-178.
69. Wallin, R., D. Cain, S.M. Hutson, D.C. Sane, R. Loeser (2000) Modulation of the binding of matrix Gla protein (MGP) to bone morphogenetic protein-2 (BMP-2). Thromb Haemost 84: 1039-1044.
70. Wang, A., J.A. Martin, L.A. Lembke, R.J. Midura (2000) Reversible suppression of in vitro biomineralization by activation of protein kinase A. J Biol Chem 275: 11082-11091.
71. Yagami, K., J.Y. Suh, M. Enomoto-Iwamoto, E. Koyama, W.R. Abrams, I.M. Shapiro, M. Pacifici, M. Iwamoto (1999) Matrix GLA protein is a developmental regulator of chondrocyte mineralization and, when constitutively expressed, blocks endochondral and intramembranous ossification in the limb. J Cell Biol 147: 1097-1108.
72. Yasuda, H., N. Shima, N. Nakagawa, K. Yamaguchi, M. Kinosaki, S. Mochizuki, A. Tomoyasu, K. Yano, M. Goto, A. Murakami, E. Tsuda, T. Morinaga, K. Higashio, N. Udagawa, N. Takahashi, T. Suda (1998) Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci USA 95: 3597-3602.
73. Zebboudj, A.F., M. Imura, K. Bostrom (2002) Matrix GLA protein, a regulatory protein for bone morphogenetic protein-2. J Biol Chem 277: 4388-4394.
74. Zebboudj, A.F., V. Shin, K. Bostrom (2003) Matrix GLA protein and BMP-2 regulate osteoinduction in calcifying vascular cells. J Cell Biochem 90: 756-765.
75. Zhao, J., P.J. Sime, P. Bringas, Jr., J.D. Tefft, S. Buckley, D. Bu, J. Gauldie, D. Warburton (1999) Spatial-specific TGF-betal adenoviral expression determines morphogenetic phenotypes in embryonic mouse lung. Eur J Cell Biol 78: 715-725.